Cardlytics (CDLX) News Today $3.16 +0.10 (+3.27%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period ROSEN, LEADING INVESTOR COUNSEL, Encourages Cardlytics, Inc. ...January 20 at 11:42 AM | gurufocus.comROSEN, LEADING INVESTOR COUNSEL, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation – CDLXJanuary 20 at 10:42 AM | globenewswire.comCardlytics' (CDLX) Hold Rating Reiterated at Needham & Company LLCJanuary 20 at 1:23 AM | americanbankingnews.comROSEN, A LEADING LAW FIRM, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLXJanuary 19 at 9:10 PM | investing.comNeedham Sticks to Its Hold Rating for Cardlytics (CDLX)January 18 at 4:52 PM | markets.businessinsider.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLXJanuary 18 at 4:17 PM | investing.comROSEN, NATIONAL TRIAL LAWYERS, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLXJanuary 17, 2025 | markets.businessinsider.comROSEN, NATIONAL TRIAL LAWYERS, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation – CDLXJanuary 17, 2025 | globenewswire.comCardlytics' (CDLX) "Hold" Rating Reiterated at Needham & Company LLCNeedham & Company LLC reissued a "hold" rating on shares of Cardlytics in a research note on Friday.January 17, 2025 | marketbeat.comCDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law FirmJanuary 17, 2025 | prnewswire.comCDLX Investor News: Rosen Law Firm Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLXJanuary 16, 2025 | prnewswire.comSecurities Fraud Investigation Into Cardlytics, Inc. (CDLX) Announced - Investors Who Lost Money Urged To Contact The Law Offices of Frank R. CruzJanuary 15, 2025 | tmcnet.comCardlytics, Inc. (CDLX) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationJanuary 14, 2025 | tmcnet.comCardlytics, Inc. (CDLX) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationJanuary 14, 2025 | businesswire.comCardlytics, Inc. Company Investigated by the Portnoy Law FirmJanuary 14, 2025 | globenewswire.comRosen Law Firm Encourages Cardlytics, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation - CDLXJanuary 14, 2025 | tmcnet.comCDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law FirmJanuary 14, 2025 | businesswire.comRosen Law Firm Encourages Cardlytics, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – CDLXJanuary 14, 2025 | businesswire.comCardlytics, Inc. (NASDAQ:CDLX) CEO Sells $21,887.88 in StockJanuary 7, 2025 | insidertrades.comAmit Gupta Sells 5,964 Shares of Cardlytics, Inc. (NASDAQ:CDLX) StockCardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CEO Amit Gupta sold 5,964 shares of the company's stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $21,887.88. Following the completion of the transaction, the chief executive officer now directly owns 186,904 shares in the company, valued at approximately $685,937.68. This represents a 3.09 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.January 6, 2025 | marketbeat.comInsider Selling: Cardlytics, Inc. (NASDAQ:CDLX) Insider Sells 6,464 Shares of StockCardlytics, Inc. (NASDAQ:CDLX - Get Free Report) insider Nicholas Hollmeyer Lynton sold 6,464 shares of Cardlytics stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $23,722.88. Following the completion of the sale, the insider now directly owns 91,771 shares of the company's stock, valued at $336,799.57. The trade was a 6.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.January 6, 2025 | marketbeat.comCardlytics, Inc. (NASDAQ:CDLX) CFO Sells $32,494.18 in StockCardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CFO Alexis Desieno sold 8,854 shares of the firm's stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $3.67, for a total transaction of $32,494.18. Following the completion of the sale, the chief financial officer now owns 121,976 shares in the company, valued at $447,651.92. This represents a 6.77 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.January 6, 2025 | marketbeat.comCardlytics, Inc. (NASDAQ:CDLX) Given Average Rating of "Hold" by AnalystsCardlytics, Inc. (NASDAQ:CDLX - Get Free Report) has earned an average recommendation of "Hold" from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigneJanuary 5, 2025 | marketbeat.comNorthland Securities Keeps Their Hold Rating on Cardlytics (CDLX)December 11, 2024 | markets.businessinsider.comCardlytics, Inc. (NASDAQ:CDLX) Receives Average Rating of "Hold" from AnalystsShares of Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) have been given an average rating of "Hold" by the seven brokerages that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one hasDecember 11, 2024 | marketbeat.comCardlytics Continues Revenue Contraction Amid Worsening EconomicsDecember 6, 2024 | seekingalpha.comWhy Is Cardlytics, Inc. (CDLX) Among The Best Advertising Stocks to Buy According to Hedge Funds?December 6, 2024 | msn.comCardlytics, Inc. (NASDAQ:CDLX) Holdings Raised by RBF Capital LLCRBF Capital LLC increased its holdings in Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 311.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 488,128 shares of the company's stock after acquDecember 5, 2024 | marketbeat.comCardlytics, Inc. (NASDAQ:CDLX) Sees Significant Drop in Short InterestCardlytics, Inc. (NASDAQ:CDLX - Get Free Report) saw a large decrease in short interest during the month of October. As of October 31st, there was short interest totalling 7,100,000 shares, a decrease of 6.7% from the October 15th total of 7,610,000 shares. Based on an average daily volume of 907,300 shares, the short-interest ratio is presently 7.8 days.November 18, 2024 | marketbeat.comInsider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CFO Sells 25,118 Shares of StockNovember 16, 2024 | insidertrades.comCardlytics, Inc. (NASDAQ:CDLX) Given Consensus Recommendation of "Hold" by BrokeragesCardlytics, Inc. (NASDAQ:CDLX - Get Free Report) has been assigned a consensus recommendation of "Hold" from the seven brokerages that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and onNovember 16, 2024 | marketbeat.comCardlytics, Inc. (NASDAQ:CDLX) CFO Sells $86,154.74 in StockCardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CFO Alexis Desieno sold 25,118 shares of the company's stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $3.43, for a total value of $86,154.74. Following the transaction, the chief financial officer now directly owns 116,481 shares of the company's stock, valued at approximately $399,529.83. This represents a 17.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.November 15, 2024 | marketbeat.comGSA Capital Partners LLP Has $1.22 Million Stake in Cardlytics, Inc. (NASDAQ:CDLX)GSA Capital Partners LLP lifted its stake in shares of Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 1,273.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 382,315 shares of the company's stock afteNovember 15, 2024 | marketbeat.comBaillie Gifford & Co. Sells 261,874 Shares of Cardlytics, Inc. (NASDAQ:CDLX)Baillie Gifford & Co. trimmed its holdings in shares of Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 31.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 567,396 shares of the company's stock after selling 261,874 sharNovember 14, 2024 | marketbeat.comCardlytics Faces Revenue Challenges and Uncertain Earnings Visibility Amid TransitionNovember 11, 2024 | markets.businessinsider.comCardlytics (NASDAQ:CDLX) Announces Earnings ResultsCardlytics (NASDAQ:CDLX - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.18. Cardlytics had a negative net margin of 50.21% and a negative return on equity of 17.96%. The business had revenue of $67.06 million for the quarter, compared to analyst estimates of $57.77 million. During the same quarter in the previous year, the firm posted ($0.26) earnings per share. Cardlytics's quarterly revenue was down 15.1% on a year-over-year basis.November 9, 2024 | marketbeat.comCardlytics (NASDAQ:CDLX) Stock Rating Upgraded by Craig HallumCraig Hallum upgraded Cardlytics from a "hold" rating to a "strong-buy" rating in a research report on Wednesday.November 8, 2024 | marketbeat.comAnalysts Have Conflicting Sentiments on These Communication Services Companies: Zillow Group Class A (ZG), Take-Two (TTWO) and Cardlytics (CDLX)November 7, 2024 | markets.businessinsider.comCardlytics (NASDAQ:CDLX) Stock Quotes, Forecast and News SummaryNovember 7, 2024 | benzinga.comCardlytics (CDLX) Gets a Hold from Lake StreetNovember 7, 2024 | markets.businessinsider.comCardlytics' (CDLX) "Hold" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reiterated a "hold" rating on shares of Cardlytics in a report on Thursday.November 7, 2024 | marketbeat.comCardlytics Reports Q3 2024 Financial ResultsNovember 7, 2024 | markets.businessinsider.comCardlytics Shares Fall on Wider 3Q LossNovember 6, 2024 | marketwatch.comCardlytics Announces Third Quarter 2024 Financial ResultsNovember 6, 2024 | globenewswire.comCardlytics Appoints Srishti Gupta to Board of DirectorsNovember 6, 2024 | markets.businessinsider.comCardlytics (CDLX) Gets a Buy from Craig-HallumNovember 6, 2024 | markets.businessinsider.comCardlytics Q3 2024 Earnings PreviewNovember 6, 2024 | msn.comCardlytics, Inc. (NASDAQ:CDLX) Short Interest Down 8.2% in OctoberCardlytics, Inc. (NASDAQ:CDLX - Get Free Report) was the target of a significant drop in short interest in the month of October. As of October 15th, there was short interest totalling 7,610,000 shares, a drop of 8.2% from the September 30th total of 8,290,000 shares. Based on an average trading volume of 1,200,000 shares, the days-to-cover ratio is presently 6.3 days.October 30, 2024 | marketbeat.comCardlytics (CDLX) to Release Earnings on WednesdayCardlytics (NASDAQ:CDLX) will be releasing earnings after the market closes on Wednesday, November 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639563)October 30, 2024 | marketbeat.comInsider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells 22,607 Shares of StockOctober 25, 2024 | insidertrades.com Get Cardlytics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter. Email Address CDLX Media Mentions By Week CDLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDLX News Sentiment▼0.120.52▲Average Business Services News Sentiment CDLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDLX Articles This Week▼194▲CDLX Articles Average Week Get Cardlytics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies YALA News MGIC News SLP News RXT News PRCH News CRNC News DOYU News CANG News RZLV News RDVT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDLX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardlytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardlytics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDLX Stock Alerts